Therapeutic use of VEGF-C and CCBE1

Research output: Patent

Abstract

The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.
Original languageEnglish
Publication Year19 Feb 2015
Publication statusPublished - 19 Feb 2015
MoE publication typeH1 Granted patent

Fields of Science

  • 3111 Biomedicine

Cite this